Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

Introduction Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes therapy 2015-09, Vol.6 (3), p.303-316
Hauptverfasser: Ascher-Svanum, Haya, Zagar, Anthony, Jiang, Dingfeng, Schuster, Dara, Schmitt, Henry, Dennehy, Ellen B., Kendall, David M., Raskin, Joel, Heine, Robert J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 316
container_issue 3
container_start_page 303
container_title Diabetes therapy
container_volume 6
creator Ascher-Svanum, Haya
Zagar, Anthony
Jiang, Dingfeng
Schuster, Dara
Schmitt, Henry
Dennehy, Ellen B.
Kendall, David M.
Raskin, Joel
Heine, Robert J.
description Introduction Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a 24-month, prospective, observational, non-interventional study evaluating glycemic response following insulin initiation for T2DM. Methods We analyzed data from a 24-month, prospective, observational study that evaluated glycemic response in patients with T2DM who initiated insulin therapy ( N  = 985) in 5 European countries. Secondary measures included patient-reported diagnosis of depression at baseline, severity of depressed/anxious mood (EuroQol (EQ)-5D item) and diabetes-related distress (Psychological Distress domain of the Diabetes Health Profile, DHP-18). The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetes-related distress. Results Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without. HbA1c of patients with or without depressed mood was not significantly different at baseline. The proportion of patients with depressed mood declined after insulin initiation, whereas the proportion of patients with high diabetes-related distress did not significantly change. HbA1c improved following insulin initiation, regardless of presence/absence of studied depression/distress parameters at baseline. Conclusion History of diagnosed depression, diabetes-related distress, and depressed mood were associated with a higher rate of microvascular complications. Diagnosed depression and diabetes-related distress also showed higher HbA1c at baseline when insulin was initiated. Insulin therapy improved glycemic control, while preexisting depressed mood declined an
doi_str_mv 10.1007/s13300-015-0118-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4575299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3811484091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-e3bcc471eaa30198f309dcdab357ca4c8dc8300e2196a4feff63a854016584e13</originalsourceid><addsrcrecordid>eNp1UsFu1DAQtRCIVks_gAuyxIXDBuw4TmIOSNttaSsVwQHOlteZFFdZe_E4QP6Iz8RL2lVBwpI1I703bzzjR8hzzl5zxpo3yIVgrGBc5svbYnpEjnlbq6JWNX98yKU4IieItywfoZTi_Ck5KmsulRLymPxaIQbrTHLBIz2F9APA04thsrB1lq6DTzEMS3oGuwiI0NEPIXRLuh6cd9YM90AuX1LjO3rmzAYSYE4w7ZEs2ocIf8BVnyDSK49jLs_RpbnzW7ry9PznbgjRpBCnJf0UMNHLYDNghgkdPiNPejMgnNzFBfny_vzz-rK4_nhxtV5dF1aKOhUgNtZWDQdjBOOq7QVTne3MRsjGmsq2nW3z2qDkqjZVD31fC9PKivFathVwsSDvZt3duNlCZyEvwAx6F93WxEkH4_TfiHdf9U34rivZyDIvdUFe3QnE8G0ETHrr0MIwGA9hRM0bLlRVlpxl6st_qLdhjHngmdUIVtUis_jMsjEgRugPj-FM762gZyvobAW9t4Kecs2Lh1McKu4_PhPKmYAZ8jcQH7T-r-pvn_3CAQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1713730463</pqid></control><display><type>article</type><title>Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ascher-Svanum, Haya ; Zagar, Anthony ; Jiang, Dingfeng ; Schuster, Dara ; Schmitt, Henry ; Dennehy, Ellen B. ; Kendall, David M. ; Raskin, Joel ; Heine, Robert J.</creator><creatorcontrib>Ascher-Svanum, Haya ; Zagar, Anthony ; Jiang, Dingfeng ; Schuster, Dara ; Schmitt, Henry ; Dennehy, Ellen B. ; Kendall, David M. ; Raskin, Joel ; Heine, Robert J.</creatorcontrib><description>Introduction Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a 24-month, prospective, observational, non-interventional study evaluating glycemic response following insulin initiation for T2DM. Methods We analyzed data from a 24-month, prospective, observational study that evaluated glycemic response in patients with T2DM who initiated insulin therapy ( N  = 985) in 5 European countries. Secondary measures included patient-reported diagnosis of depression at baseline, severity of depressed/anxious mood (EuroQol (EQ)-5D item) and diabetes-related distress (Psychological Distress domain of the Diabetes Health Profile, DHP-18). The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetes-related distress. Results Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without. HbA1c of patients with or without depressed mood was not significantly different at baseline. The proportion of patients with depressed mood declined after insulin initiation, whereas the proportion of patients with high diabetes-related distress did not significantly change. HbA1c improved following insulin initiation, regardless of presence/absence of studied depression/distress parameters at baseline. Conclusion History of diagnosed depression, diabetes-related distress, and depressed mood were associated with a higher rate of microvascular complications. Diagnosed depression and diabetes-related distress also showed higher HbA1c at baseline when insulin was initiated. Insulin therapy improved glycemic control, while preexisting depressed mood declined and diabetes-related distress remained unchanged.</description><identifier>ISSN: 1869-6953</identifier><identifier>EISSN: 1869-6961</identifier><identifier>DOI: 10.1007/s13300-015-0118-y</identifier><identifier>PMID: 26159935</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Diabetes ; Endocrinology ; Insulin ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Mental depression ; Original Research</subject><ispartof>Diabetes therapy, 2015-09, Vol.6 (3), p.303-316</ispartof><rights>The Author(s) 2015</rights><rights>Springer Healthcare 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-e3bcc471eaa30198f309dcdab357ca4c8dc8300e2196a4feff63a854016584e13</citedby><cites>FETCH-LOGICAL-c536t-e3bcc471eaa30198f309dcdab357ca4c8dc8300e2196a4feff63a854016584e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575299/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575299/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,27907,27908,41103,42172,51559,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26159935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ascher-Svanum, Haya</creatorcontrib><creatorcontrib>Zagar, Anthony</creatorcontrib><creatorcontrib>Jiang, Dingfeng</creatorcontrib><creatorcontrib>Schuster, Dara</creatorcontrib><creatorcontrib>Schmitt, Henry</creatorcontrib><creatorcontrib>Dennehy, Ellen B.</creatorcontrib><creatorcontrib>Kendall, David M.</creatorcontrib><creatorcontrib>Raskin, Joel</creatorcontrib><creatorcontrib>Heine, Robert J.</creatorcontrib><title>Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis</title><title>Diabetes therapy</title><addtitle>Diabetes Ther</addtitle><addtitle>Diabetes Ther</addtitle><description>Introduction Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a 24-month, prospective, observational, non-interventional study evaluating glycemic response following insulin initiation for T2DM. Methods We analyzed data from a 24-month, prospective, observational study that evaluated glycemic response in patients with T2DM who initiated insulin therapy ( N  = 985) in 5 European countries. Secondary measures included patient-reported diagnosis of depression at baseline, severity of depressed/anxious mood (EuroQol (EQ)-5D item) and diabetes-related distress (Psychological Distress domain of the Diabetes Health Profile, DHP-18). The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetes-related distress. Results Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without. HbA1c of patients with or without depressed mood was not significantly different at baseline. The proportion of patients with depressed mood declined after insulin initiation, whereas the proportion of patients with high diabetes-related distress did not significantly change. HbA1c improved following insulin initiation, regardless of presence/absence of studied depression/distress parameters at baseline. Conclusion History of diagnosed depression, diabetes-related distress, and depressed mood were associated with a higher rate of microvascular complications. Diagnosed depression and diabetes-related distress also showed higher HbA1c at baseline when insulin was initiated. Insulin therapy improved glycemic control, while preexisting depressed mood declined and diabetes-related distress remained unchanged.</description><subject>Cardiology</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Insulin</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental depression</subject><subject>Original Research</subject><issn>1869-6953</issn><issn>1869-6961</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1UsFu1DAQtRCIVks_gAuyxIXDBuw4TmIOSNttaSsVwQHOlteZFFdZe_E4QP6Iz8RL2lVBwpI1I703bzzjR8hzzl5zxpo3yIVgrGBc5svbYnpEjnlbq6JWNX98yKU4IieItywfoZTi_Ck5KmsulRLymPxaIQbrTHLBIz2F9APA04thsrB1lq6DTzEMS3oGuwiI0NEPIXRLuh6cd9YM90AuX1LjO3rmzAYSYE4w7ZEs2ocIf8BVnyDSK49jLs_RpbnzW7ry9PznbgjRpBCnJf0UMNHLYDNghgkdPiNPejMgnNzFBfny_vzz-rK4_nhxtV5dF1aKOhUgNtZWDQdjBOOq7QVTne3MRsjGmsq2nW3z2qDkqjZVD31fC9PKivFathVwsSDvZt3duNlCZyEvwAx6F93WxEkH4_TfiHdf9U34rivZyDIvdUFe3QnE8G0ETHrr0MIwGA9hRM0bLlRVlpxl6st_qLdhjHngmdUIVtUis_jMsjEgRugPj-FM762gZyvobAW9t4Kecs2Lh1McKu4_PhPKmYAZ8jcQH7T-r-pvn_3CAQ</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ascher-Svanum, Haya</creator><creator>Zagar, Anthony</creator><creator>Jiang, Dingfeng</creator><creator>Schuster, Dara</creator><creator>Schmitt, Henry</creator><creator>Dennehy, Ellen B.</creator><creator>Kendall, David M.</creator><creator>Raskin, Joel</creator><creator>Heine, Robert J.</creator><general>Springer Healthcare</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150901</creationdate><title>Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis</title><author>Ascher-Svanum, Haya ; Zagar, Anthony ; Jiang, Dingfeng ; Schuster, Dara ; Schmitt, Henry ; Dennehy, Ellen B. ; Kendall, David M. ; Raskin, Joel ; Heine, Robert J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-e3bcc471eaa30198f309dcdab357ca4c8dc8300e2196a4feff63a854016584e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiology</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Insulin</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental depression</topic><topic>Original Research</topic><toplevel>online_resources</toplevel><creatorcontrib>Ascher-Svanum, Haya</creatorcontrib><creatorcontrib>Zagar, Anthony</creatorcontrib><creatorcontrib>Jiang, Dingfeng</creatorcontrib><creatorcontrib>Schuster, Dara</creatorcontrib><creatorcontrib>Schmitt, Henry</creatorcontrib><creatorcontrib>Dennehy, Ellen B.</creatorcontrib><creatorcontrib>Kendall, David M.</creatorcontrib><creatorcontrib>Raskin, Joel</creatorcontrib><creatorcontrib>Heine, Robert J.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ascher-Svanum, Haya</au><au>Zagar, Anthony</au><au>Jiang, Dingfeng</au><au>Schuster, Dara</au><au>Schmitt, Henry</au><au>Dennehy, Ellen B.</au><au>Kendall, David M.</au><au>Raskin, Joel</au><au>Heine, Robert J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis</atitle><jtitle>Diabetes therapy</jtitle><stitle>Diabetes Ther</stitle><addtitle>Diabetes Ther</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>6</volume><issue>3</issue><spage>303</spage><epage>316</epage><pages>303-316</pages><issn>1869-6953</issn><eissn>1869-6961</eissn><abstract>Introduction Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This exploratory, post hoc analysis investigated associations between depression parameters and glycemic control using data from a 24-month, prospective, observational, non-interventional study evaluating glycemic response following insulin initiation for T2DM. Methods We analyzed data from a 24-month, prospective, observational study that evaluated glycemic response in patients with T2DM who initiated insulin therapy ( N  = 985) in 5 European countries. Secondary measures included patient-reported diagnosis of depression at baseline, severity of depressed/anxious mood (EuroQol (EQ)-5D item) and diabetes-related distress (Psychological Distress domain of the Diabetes Health Profile, DHP-18). The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetes-related distress. Results Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without. HbA1c of patients with or without depressed mood was not significantly different at baseline. The proportion of patients with depressed mood declined after insulin initiation, whereas the proportion of patients with high diabetes-related distress did not significantly change. HbA1c improved following insulin initiation, regardless of presence/absence of studied depression/distress parameters at baseline. Conclusion History of diagnosed depression, diabetes-related distress, and depressed mood were associated with a higher rate of microvascular complications. Diagnosed depression and diabetes-related distress also showed higher HbA1c at baseline when insulin was initiated. Insulin therapy improved glycemic control, while preexisting depressed mood declined and diabetes-related distress remained unchanged.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>26159935</pmid><doi>10.1007/s13300-015-0118-y</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1869-6953
ispartof Diabetes therapy, 2015-09, Vol.6 (3), p.303-316
issn 1869-6953
1869-6961
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4575299
source DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Cardiology
Diabetes
Endocrinology
Insulin
Internal Medicine
Medicine
Medicine & Public Health
Mental depression
Original Research
title Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A18%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Associations%20Between%20Glycemic%20Control,%20Depressed%20Mood,%20Clinical%20Depression,%20and%20Diabetes%20Distress%20Before%20and%20After%20Insulin%20Initiation:%20An%20Exploratory,%20Post%20Hoc%20Analysis&rft.jtitle=Diabetes%20therapy&rft.au=Ascher-Svanum,%20Haya&rft.date=2015-09-01&rft.volume=6&rft.issue=3&rft.spage=303&rft.epage=316&rft.pages=303-316&rft.issn=1869-6953&rft.eissn=1869-6961&rft_id=info:doi/10.1007/s13300-015-0118-y&rft_dat=%3Cproquest_pubme%3E3811484091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1713730463&rft_id=info:pmid/26159935&rfr_iscdi=true